Tiam1 Drives Polarized Protrusion Outgrowth pp. 4--14
=====================================================

Successful tissue development and repair is dependent on cell migration, which is itself contingent on cell polarization and protrusion. Rho GTPases are an established factor in the establishment and maintenance of cell polarity, however the initial signaling pathway leading to Rho activation is not yet understood. In this research paper, Saskia Ellenbroek, Sandra Iden and John Collard use murine primary astrocyte cultures to study factors involved in polarized outgrowth and protrusion. After scratch-wounding a monolayer of cells, the team found that Tiam1, a specific activator of Rac, is required for cell polarization and protrusion. As centrosome and Golgi positioning were unaffected by Tiam1, the authors suggest that Tiam1\'s involvement is delegated to microtubule organization.

It\'s Due to the Residue pp. 15--22
===================================

The Rho family of small GTPases are involved in many important cellular processes, such as migration, transformation and proliferation. Although Rho A, B and C share 85% of their amino acid sequences, these GTPases control very different cellular events. These differences may be due to each Rho GTPase\'s ability for unique activation by guanine nucleotide exchange factors (GEFs). In this research paper, Sloan et al. use a residue swap approach to successfully support their hypothesis that it is the amino acid variation at residue 43 that determines GEF activity.

Uncommon Descent of Membrane Trafficking Pathways pp. 23--7
===========================================================

Transporting proteins in eukaryotes is a critical process involving tightly regulated membrane trafficking pathways. How the cargo proteins are sorted and where they are transported is mediated by different membrane trafficking pathways that employ specific sets of Rab GTPases and SNAREs. Due to the importance of correct protein trafficking, it is not surprising that some groups of RAB GTPases involved in trafficking pathways are highly conserved among eukaryotes. However, some RAB groups appear haphazardly or only in specific lineages, indicating that not all RAB groups have arisen from a common ancestor. In this commentary, Ebine et al. discuss their findings that a trafficking pathway similar in both plants and animals have differing underlying molecular machineries, thus not sharing a similar ancestor (Nat Cell Biol 2011; DOI: 10.1038/ncb2270). Interestingly, the plant specific RAB GTPase in this pathway is also involved in the salt-stress response of *A. thaliana*, suggesting that novel trafficking pathways may be selected for in a lineage-specific manner.

The Abduction of Rab1 by *L. pneumophila* pp. 28--33
====================================================

Exploiting a host organism while hiding undetected is the aim of most bacterial pathogens. One key way in which these pathogens can selfishly hijack the environment and avoid detection is by tampering with protein trafficking pathways. This can be done by toggling GTPases on an off by switching the GTP bound state to a GDP bound state, respectively. In this commentary, M. Ramona Neunuebel and Matthias P. Machner reveal how the pathogen, *L. pneumophila*, hijacks Rab1, the small GTPase that regulates the ER-to-Golgi vesicle transport pathway, by recruiting it to a specialized replication vacuole where it is then manipulated (Science 2011; DOI:10.1126/science.1207193). Similar domains and adaptability among other bacterial species suggests that the control and localization of GTPases may not be unique to *L. pneumophila*.

Special Treatment for KRAS Mutants in Colorectal Cancer pp. 34--9
=================================================================

Nearly half of all colorectal cancer cases in the US will eventually metastasize and become one of the deadliest human cancers. A large percentage of metastatic colorectal cancer (mCRC) tumors overexpress epidermal growth factor receptors (EGFR) and therefore many treatments rely on the blockage and inhibition of these receptors. However, oncogenic signaling cascades can be activated independently of EGFRs, such as in tumors with a mutation in the small GTPase, KRAS. These tumors are unaffected by blocking EGFR, requiring alternative treatments. In this commentary, Toni Brand and Deric Wheeler review existing treatments for KRAS mutant tumors with an emphasis on optimal therapies that include multimodal approaches and stratification of KRAS mutations in response to varying treatments.

Rhou Controls Endoderm Development pp. 40--4
============================================

During embryogenesis, cells from the endoderm eventually differentiate into specific tissues that comprise parts of the digestive, respiratory and other systems. The expression of an atypical Rho GTPase, Rhou, is responsible for turning the featureless cells of endoderm into a columnar structure, and thereafter, the downregulation of Rhou allows for the subsequent layering of the epithelium. While much is known about the roles of Rho-related small GTPases in later epithelial tissue development, little is known about their role in earlier developmental stages, such as in endoderm. In this commentary, Daniel Loebel and Patrick Tam review their recent study of Rhou\'s role in many stages of endoderm differentiation (Development 2011; DOI:10.1242/dev.063867). The authors contend that Rhou may also induce budding and expansion from single layer epithelium.

BAR-Domain Control of Rho GTPases pp. 45--52
============================================

Cell migration is orchestrated by cytoskeletal dynamics that are, in turn, directed by Rho GTPases. Misbehaving Rho GTPases can lead to a multitude of morphogenetic aberrations, therefore, their activity is strictly monitored. Plasma membrane trafficking is one way that Rho GTPases are controlled, with the active form normally associated with the membrane. In this commentary, Bart-Jan de Kreuk and Peter Hordijk refer to their recent paper discussing BAR-domain proteins that interface between Rho GTPase signaling and membrane dynamics (J Cell Sci 2011, DOI: 10.1242/​jcs.080630). The authors describe different methods of how BAR proteins can regulate Rho GTPases, thus pointing to the importance of BAR-domain proteins in linking membrane trafficking with cytoskeletal dynamics.

HA/CD44 Interaction as a Potential Cancer Drug Target pp. 53--9
===============================================================

Cancer progression to metastasis and tumor invasion is the main cause of morbidity in cancer patients. Preventing this invasion is the aim of many therapies and novel drug targets are in high demand. Adhesion molecules, such as hyaluronan (HA), have been identified in the progression of migrative behaviors. HA is particularly germane as it is also enriched in many tumor types. In this commentary, Lilly Bourguignon details the signaling pathway of HA, from its binding to CD44 to the consequent activation of miRNA-signaling and Rho GTPases, leading to many tumor cell activities, including invasion (J Biol Chem 2010; DOI:10.1074/jbc.M110.162). These findings potentially make the HA/CD44 signaling cascade an attractive target for new drug therapies.

The Endless Rac1 Cycle pp. 60--6
================================

Rac1, a member of the Rho/Rac GTPase family, has its hand in a number of essential cellular processes. Some of these include cell adhesion and proliferation, axon migration and guidance, phagocytosis and even the creation of the immunological synapse. With all these undertakings, it is no surprise that the functional cycle of Rac1 is well described. In this commentary, Bustelo et al. review current research on the regulation of the many steps in the Rac1 cycle. The authors also describe their own recent findings of a cytoskeletal-dependent feed-back loop for efficient transport and activation of Rac proteins during signaling (EMBO J 2011: DOI:10.1038/emboj.2011.3). The authors note the importance of this pathway for optimal functioning of Rac1 activation through select receptors.

Apply Rac1 to Stop the Bleeding pp. 67--70
==========================================

We would be in trouble if it wasn\'t for the tiresome job of platelets that detect blood vessel injury and quickly plug them to prevent undesired bleeding. This actin- driven activity is, in part, driven by Rac1 and is central to blood clot stability. But how is Rac1 regulated by platelets? In this commentary, Joseph Aslan and Owen McCarty demonstrate how platelet Rac1 is activated by mTOR and highlight the critical role this pathway has on the regulation of platelet spreading, aggregation and stability (Blood 2011; DOI: 10.1182/blood-2011-0). Understanding this mTOR system may open up new avenues of cancer therapy and transplant medicine to control and optimize hemostatic processes.
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